Risk of overactive bladder associated with medications for dementia

drug
Credit: Unsplash/CC0 Public Domain

A study from the University of Houston College of Pharmacy, published in the Journal of the American Geriatrics Society, has evaluated the risk of overactive bladder (OAB) as a side effect of cholinesterase inhibitor (ChEI) drugs taken for dementia and Alzheimer’s disease. The research was based on the dissertation work of the study’s first author Prajakta Masurkar. 

Dementia is a group of symptoms associated with a decline in memory, reasoning or other thinking skills. Alzheimer’s disease is the most common cause of , accounting for 60%–80% of cases. ChEI drugs, including donepezil, galantamine and…

Read more…